Pamela Danagher

Pamela Danagher has extensive experience in regulatory affairs, with their most recent role being Vice President and Head of Regulatory Affairs at Terns Pharmaceuticals since August 2021. Prior to this, they held various positions at Takeda, including Executive Director and Senior Director of Regulatory Affairs from March 2018 to August 2021. Pamela also worked as a Director of Regulatory Affairs at Amgen from November 2012 to February 2018, and as a Regulatory Affairs Professional at Falcon Point Consulting from January 2012 to October 2012. Pamela has worked at Gilead Sciences as a Senior Director of Regulatory Affairs from June 2004 to July 2011, and at Amgen as a Regulatory Affairs Senior Manager from July 1998 to June 2004. Pamela has also held roles at Gensia as a Regulatory Affairs Manager from January 1996 to April 1998, at Gen-Probe Incorporated as a Regulatory Specialist in 1998, at Ibex Technologies as a Research Scientist in Cell and Molecular Biology from January 1992 to January 1996, and at The American Red Cross Society as a Research Associate from January 1991 to January 1992.

Pamela Danagher holds a Master of Science degree in Biochemistry & Genetics from the University of Ottawa. Pamela also obtained a Bachelor of Science degree in Biochemistry & Genetics from Western University. Additionally, Pamela has studied Molecular Biology at McGill University.